Naloxone in France: Preventing opioid overdoses through innovative programs (notice n° 1373603)
[ vue normale ]
000 -LEADER | |
---|---|
fixed length control field | 01537cam a2200169 4500500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250629030510.0 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | fre |
042 ## - AUTHENTICATION CODE | |
Authentication code | dc |
100 10 - MAIN ENTRY--PERSONAL NAME | |
Personal name | Frauger, Elisabeth |
Relator term | author |
245 00 - TITLE STATEMENT | |
Title | Naloxone in France: Preventing opioid overdoses through innovative programs |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Date of publication, distribution, etc. | 2025.<br/> |
500 ## - GENERAL NOTE | |
General note | 16 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | In France, according to the DRAMES and DTA pharmaco-surveillance systems, the majority of drug-related deaths involve opioids. Naloxone, the antidote for opioid overdoses, has been used in medical settings since the 1970s. Since 2016, take-home naloxone (THN) has been available. Naloxone remains underutilized for several reasons, including lack of awareness about naloxone among certain professionals and users, limited access, stigma, and ignorance about overdose risks. In this context, it is important to support professionals in setting up naloxone programs to raise awareness among users and their support networks about overdose risks and the proper use of naloxone. This article first describes the different forms of THN in France and then offers guidance to addiction professionals in how to structure such programs. To illustrate this, the actions of the POP program (Prevention and risk reduction of opioid-related overdoses in the PACA region) are described in detail. |
700 10 - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chappuy, Mathieu |
Relator term | author |
786 0# - DATA SOURCE ENTRY | |
Note | Psychotropes | 31 | 2-3 | 2025-06-24 | p. 145-167 | 1245-2092 |
856 41 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-psychotropes-2025-2-3-page-145?lang=en&redirect-ssocas=7080">https://shs.cairn.info/journal-psychotropes-2025-2-3-page-145?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux